In conclusion, we demonstrated that the control of thyroid differentiation‐related transcription factors via the METTL3‐SETMAR‐SMARCA2 axis contributes to the differentiation of thyroid cancer. The gene discussed is METTL3; the disease is thyroid gland carcinoma.